3.0.0 4467 2023-08-14T18:00:27Z 2023-08-14T18:00:27Z Senate S 2022-06-23 117 sshr00 Health, Education, Labor, and Pensions Committee Senate Standing Referred to 2022-06-23T17:15:08Z Protecting Access to Medication Abortion Act 117 8405 HR 2022-07-18 Referred to the House Committee on Energy and Commerce. Identical bill CRS 2022-06-23 sshr00 Health, Education, Labor, and Pensions Committee Senate Read twice and referred to the Committee on Health, Education, Labor, and Pensions. IntroReferral 2022-06-23 Introduced in Senate IntroReferral 10000 9 Library of Congress S001203 Sen. Smith, Tina [D-MN] Tina Smith D MN N B001288 Sen. Booker, Cory A. [D-NJ] Cory Booker D NJ 2022-07-11 False G000555 Sen. Gillibrand, Kirsten E. [D-NY] Kirsten Gillibrand D NY E. 2022-07-11 False S001194 Sen. Schatz, Brian [D-HI] Brian Schatz D HI 2022-07-11 False W000802 Sen. Whitehouse, Sheldon [D-RI] Sheldon Whitehouse D RI 2022-07-11 False H000273 Sen. Hickenlooper, John W. [D-CO] John Hickenlooper D CO W. 2022-07-11 False S000770 Sen. Stabenow, Debbie [D-MI] Debbie Stabenow D MI 2022-07-11 False M001176 Sen. Merkley, Jeff [D-OR] Jeff Merkley D OR 2022-07-12 False P000145 Sen. Padilla, Alex [D-CA] Alex Padilla D CA 2022-07-13 False K000384 Sen. Kaine, Tim [D-VA] Timothy Kaine D VA M. 2022-07-13 False K000383 Sen. King, Angus S., Jr. [I-ME] Angus King I ME S. 2022-07-20 False Health Abortion Health care coverage and access Health technology, devices, supplies Prescription drugs Health 00 2022-06-23 Introduced in Senate 2023-08-14T17:57:59Z Protecting Access to Medication Abortion Act

This bill directs the Food and Drug Administration (FDA) to take steps to allow patients to receive prescriptions for mifepristone, a drug approved by the FDA for medical abortion, via telehealth and for prescriptions for the drug to be filled by mail.

(Mifepristone is subject to a Risk Evaluation and Mitigation Strategy, which imposes various safety-related requirements. During the COVID-19 public health emergency, the FDA suspended enforcement of the current strategy's requirement that the drug must be dispensed in person, and this suspension is still in effect. In December 2021, the FDA stated the data supported modifying the strategy to remove the in-person dispensing requirement.)

Under this bill, the FDA must require the holder of the relevant approved drug application to submit a proposal to modify the strategy. The modification shall (1) remove the in-person dispensing requirement, (2) allow patients to access prescriptions for mifepristone via telehealth, and (3) authorize all pharmacies certified to dispense mifepristone to patients to do so via mail.

]]> Protecting Access to Medication Abortion Act Display Title Protecting Access to Medication Abortion Act Short Title(s) as Introduced Protecting Access to Medication Abortion Act Introduced in Senate IS Official Title as Introduced A bill to preserve access to abortion medications. Introduced in Senate IS Introduced in Senate 2022-06-23T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-117s4467is/xml/BILLS-117s4467is.xml 2022-06-23 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.